CIK 0001708688 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in P7 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-22 | 6-K | 6-K | 2026-10-22 |
| 2026-08-17 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | 424B5 | 425B5 | |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | EFFECT | EFFECT items ,, | |
| 2026-08-06 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-06 | F-3 | F-3 | |
| 2026-08-06 | S-8 | S-8 | |
| 2026-08-06 | 6-K | 6-K | 2026-08-06 |
| 2026-06-30 | 6-K | 6-K | 2026-06-30 |
| 2026-05-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-12 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-07 | 6-K | 6-K | 2026-05-07 |
| 2026-05-07 | 424B5 | 424B5 | |
| 2026-05-06 | 424B5 | 424B5 | |
| 2026-05-06 | 6-K | 6-K | 2026-05-06 |
| 2026-05-06 | 6-K | 6-K | 2026-03-31 |
| 2026-05-04 | 6-K | 6-K | 2026-05-04 |
| 2026-04-28 | 6-K | 6-K | 2026-04-28 |
| 2026-04-23 | 6-K | 6-K | 2026-04-23 |
| 2026-04-09 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-04-09 |
| 2026-04-02 | 6-K | 6-K | 2026-04-02 |
| 2026-03-20 | 20-F | ANNUAL REPORT | 2025-12-31 |
Forms on file (last 1,000): 6-K 152, SC 13G/A 21, SC 13G 17, 424B5 12, CORRESP 12, UPLOAD 11, 3 9, 20-F 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=IFRX (0.002 USD), /gw/filings/filings?ticker=IFRX&form=8-K, /gw/filings/facts?ticker=IFRX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange